Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study
出版年份 2023 全文链接
标题
Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study
作者
关键词
-
出版物
RENAL FAILURE
Volume 45, Issue 2, Pages -
出版商
Informa UK Limited
发表日期
2023-10-31
DOI
10.1080/0886022x.2023.2256418
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro
- (2021) Akira Miyama et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
- (2021) Jun Tao et al. Frontiers in Immunology
- Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways
- (2020) Chang-hong Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis
- (2019) Charat Thongprayoon et al. Archives of Osteoporosis
- Molecular mechanisms and clinical application of Iguratimod: A review
- (2019) Huihui Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: its efficacy, radiographic changes, safety and predictors over two years’ treatment for Japanese rheumatoid arthritis patients
- (2018) Koichiro Ishikawa et al. Modern Rheumatology
- T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB
- (2018) Jinglue Song et al. Biomed Research International
- Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol
- (2018) Pieter Evenepoel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis
- (2017) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-κB and MAPK pathways
- (2016) Ke Gan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation
- (2016) Shun-Li Kan et al. MEDICINE
- A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation
- (2016) Myles Wolf et al. TRANSPLANTATION
- Importance of Vascular Calcification in Kidney Transplant Recipients
- (2014) Giuseppe Cianciolo et al. AMERICAN JOURNAL OF NEPHROLOGY
- Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial
- (2014) Naoki Ishiguro et al. Modern Rheumatology
- Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients
- (2013) Pieter Evenepoel SEMINARS IN NEPHROLOGY
- Fracture Risk in Kidney Transplant Recipients
- (2013) Kyla L. Naylor et al. TRANSPLANTATION
- Progression of coronary artery calcification in renal transplant recipients
- (2011) Nurhan Seyahi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway
- (2009) Sara Panizo et al. CIRCULATION RESEARCH
- Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation
- (2008) P. Evenepoel et al. Clinical Journal of the American Society of Nephrology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now